Wen-Hsin Chang, Ph.D.
Wen-Hsin received her Ph.D. from the Institute of Molecular Medicine, National Taiwan University. She is currently participating in cancer studies involving the MTAP-MTA axis and protein methylomics. Her current work revolves around identifying crosstalk interactions between methylation and other kinds of post-translational modifications. In addition, she is engaged in metabolomics research to elucidate the metabolic alterations in response to MTAP deletion in lung cancer and RCC.
So-Yi Chang, Ph.D.
So-Yi Chang received her PhD degree at the Institute of Biochemistry and Molecular Biology in College of Medicine/National Taiwan University. Dr. Chang’s research has been focused on investigating the role of the interaction of p53 and SP110 (a nuclear body protein that is involved in the regulation of transcription, cell division, apoptosis, senescence, and response to DNA damage or infection) in lung cancer and also on identifying the SP110 gene polymorphisms that are potential genetic markers associated with active tuberculosis infection in Taiwan. Dr. Chang is an easy-going, friendly and conscientious person. In research studies, she reveals passion, curiosity and has strong action to do study works. Currently, she is a postdoc in Dr. Ching-Hsien Chen’s lab. Her current research project focuses on revealing the mechanisms of MARCKS PSD peptide inhibitor (MPS) in lung cancer. She also works on the MARCKS biological function in macrophages during lung inflammation.